APA (7th ed.) Citation

Bravo Thompson, H., Chattopadhyay, P., Subhawong, T., Palmer, M., Torralbas Fitz, S., Crawford, B., . . . Jonczak, E. (2026). MRI-Based Delta Necrosis as a Prognostic Marker Following Neoadjuvant Chemotherapy in Soft Tissue Sarcoma. Cancers, 18(2), 291. https://doi.org/10.3390/cancers18020291

Chicago Style (17th ed.) Citation

Bravo Thompson, Harold, Priya Chattopadhyay, Ty Subhawong, Malcolm-Christopher Palmer, Sergio Torralbas Fitz, Brooke Crawford, Andrew Rosenberg, H. Thomas Temple, and Emily Jonczak. "MRI-Based Delta Necrosis as a Prognostic Marker Following Neoadjuvant Chemotherapy in Soft Tissue Sarcoma." Cancers 18, no. 2 (2026): 291. https://doi.org/10.3390/cancers18020291.

MLA (9th ed.) Citation

Bravo Thompson, Harold, et al. "MRI-Based Delta Necrosis as a Prognostic Marker Following Neoadjuvant Chemotherapy in Soft Tissue Sarcoma." Cancers, vol. 18, no. 2, 2026, p. 291, https://doi.org/10.3390/cancers18020291.